Jacqueline C. Shultz, Ph.D.

Affiliations: 
2009 Biochemistry Virginia Commonwealth University, Richmond, VA, United States 
Area:
Molecular Biology, Biochemistry
Google:
"Jacqueline Shultz"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Charles E. Chalfant grad student 2009 VCU
 (The regulation of alternative splicing by oncogenic signaling pathways.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Shapiro BA, Vu NT, Shultz MD, et al. (2016) Melanoma differentiation associated gene 7/IL-24 exerts cytotoxic effects by altering the alternative splicing of Bcl-x pre-mRNA via the SRC/PKCδ signaling axis. The Journal of Biological Chemistry
Barbour SE, Nguyen PT, Park M, et al. (2015) Group VIA Phospholipase A2 (iPLA2β) Modulates Bcl-x 5'-Splice Site Selection and Suppresses Anti-apoptotic Bcl-x(L) in β-Cells. The Journal of Biological Chemistry. 290: 11021-31
Vu NT, Park MA, Shultz JC, et al. (2013) HnRNP U enhances caspase-9 splicing and is modulated by AKT-dependent phosphorylation of hnRNP L Journal of Biological Chemistry. 288: 8575-8584
Shultz JC, Vu N, Shultz MD, et al. (2012) The proto-oncogene PKCι regulates the alternative splicing of Bcl-x Pre-mRNA Molecular Cancer Research. 10: 660-669
Shultz JC, Chalfant CE. (2012) The flip-flop HuR: part of the problem or the solution in fighting cancer? The Journal of Clinical Investigation. 122: 16-9
Shultz JC, Goehe RW, Murudkar CS, et al. (2011) SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells. Molecular Cancer Research : McR. 9: 889-900
Shultz JC, Chalfant CE. (2011) Caspase 9b: a new target for therapy in non-small-cell lung cancer. Expert Review of Anticancer Therapy. 11: 499-502
Shultz JC, Goehe RW, Wijesinghe DS, et al. (2010) Alternative splicing of caspase 9 is modulated by the phosphoinositide 3-kinase/Akt pathway via phosphorylation of SRp30a. Cancer Research. 70: 9185-96
Goehe RW, Shultz JC, Murudkar C, et al. (2010) hnRNP L regulates the tumorigenic capacity of lung cancer xenografts in mice via caspase-9 pre-mRNA processing. The Journal of Clinical Investigation. 120: 3923-39
Shultz JC, Chalfant CE. (2007) Emetine and the alternative splicing of Bcl-X: where to next? Chemistry & Biology. 14: 1313-4
See more...